Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Daniel Silverman MD, PhD

Daniel Silverman MD, PhD

Head, Neuronuclear Imaging Section, Ahmanson Translational Imaging Division; Director, Brain Wellness and PET Consultation Services; Professor, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California

Daniel H. Silverman, MD, PhD, is Head of the Neuronuclear Imaging Section of the Ahmanson Translational Imaging Division at UCLA Medical Center, Executive Committee member of the UCLA Alzheimer's Disease Center, Director of the UCLA Brain Wellness consultation service and NeuroPET Clinics, and  Professor in the Department of Molecular and Medical Pharmacology, in the School of Medicine at the University of California, Los Angeles.  He previously served as Editor of PET in the Evaluation of Alzheimer's Disease and Related Disorders,(Springer, New York, 2009), the first published textbook devoted exclusively to the role of positron emission tomography in assessment of neurodegenerative disorders.  He obtained his Ph.D. in Biological Chemistry at Harvard University, postdoctoral research training in Biochemistry and Molecular Pharmacology at Harvard Medical School, his M.D. from The Ohio State University College of Medicine, and subsequently completed post-M.D. training at UCLA, before obtaining certification from both the American Board of Internal Medicine and the American Board of Nuclear Medicine. 


Professor, Molecular & Medical Pharmacology

Attending Physician, UCLA Health Nuclear Medicine Services

Head, Neuronuclear Imaging Section

Director, UCLA NeuroPET Clinics


Dr. Silverman has no relevant disclosures.